Q4 2021 · 13F-HR
ACT CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2022-02-03 · accession 0001636587-22-000001
$138,329
Reported value
92
Positions
2021-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 852312305 | STAA | STAAR SURGICAL CO | $23,565 | 17.0% | 258,100 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $17,743 | 12.8% | 479,400 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $13,956 | 10.1% | 210,500 | Common | SOLE |
| 185063104 | CLSDUSD | CLEARSIDE BIOMEDICAL INC | $6,830 | 4.94% | 2,483,500 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $4,311 | 3.12% | 188,500 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $4,127 | 2.98% | 59,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $4,102 | 2.97% | 173,500 | Common | SOLE |
| 35953D104 | FUBOGBP | FUBOTV INC | $3,577 | 2.59% | 230,500 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $3,026 | 2.19% | 32,400 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $2,917 | 2.11% | 13,500 | Common | SOLE |
| 00738A106 | — | ADTRAN INC | $2,625 | 1.90% | 115,000 | Common | SOLE |
| 30303M102 | META | META PLATFORMS INC | $2,523 | 1.82% | 7,500 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $2,428 | 1.76% | 58,000 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $2,351 | 1.70% | 230,500 | Common | SOLE |
| 44934S206 | ICADUSD | ICAD INC | $2,334 | 1.69% | 324,100 | Common | SOLE |
| M85548101 | SSYS | STRATASYS LTD | $2,290 | 1.66% | 93,500 | Common | SOLE |
| 04537Y109 | — | ASPIRA WOMENS HEALTH INC | $1,770 | 1.28% | 1,000,000 | Common | SOLE |
| 009496100 | AIRS | AIRSCULPT TECHNOLOGIES INC | $1,745 | 1.26% | 101,500 | Common | SOLE |
| 29415J106 | — | ENVVENO MED CORP | $1,730 | 1.25% | 262,500 | Common | SOLE |
| N01045108 | — | AFFIMED N V | $1,705 | 1.23% | 308,800 | Common | SOLE |
| 45719W106 | — | INHIBIKASE THERAPEUTICS INC | $1,582 | 1.14% | 1,076,500 | Common | SOLE |
| 74467Q103 | PUBM | PUBMATIC INC COM CL A | $1,532 | 1.11% | 45,000 | Common | SOLE |
| 166764100 | CVX | CHEVRON CORP NEW | $1,467 | 1.06% | 12,500 | Common | SOLE |
| M5216V106 | GLBE | GLOBAL-E ONLINE LTD | $1,426 | 1.03% | 22,500 | Common | SOLE |
| G637AM102 | — | MYOVANT SCIENCES LTD | $1,323 | 0.96% | 85,000 | Common | SOLE |
| 38246G108 | GDRX | GOODRX HLDGS INC | $1,307 | 0.94% | 40,000 | Common | SOLE |
| 98956A105 | ZETA | ZETA GLOBAL HOLDINGS CORP | $1,137 | 0.82% | 135,000 | Common | SOLE |
| 577096100 | MTTR* | MATTERPORT INC | $1,135 | 0.82% | 55,000 | Common | SOLE |
| 64049K104 | — | NEOLEUKIN THERAPEUTICS INC | $1,024 | 0.74% | 212,500 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N V | $853 | 0.62% | 63,500 | Common | SOLE |
| 91680M107 | UPST | UPSTART HLDGS INC | $847 | 0.61% | 5,600 | Common | SOLE |
| 28249U105 | CLDNEUR | EIGER BIOPHARMACEUTICALS INC | $823 | 0.59% | 158,500 | Common | SOLE |
| 68236P107 | GTXIEUR | ONCTERNAL THERAPEUTICS INC | $817 | 0.59% | 360,000 | Common | SOLE |
| 86877M209 | — | SURFACE ONCOLOGY INC | $815 | 0.59% | 170,500 | Common | SOLE |
| 19260Q107 | COIN | COINBASE GLOBAL INC | $757 | 0.55% | 3,000 | Common | SOLE |
| 52187K101 | — | LEAP THERAPEUTICS INC | $729 | 0.53% | 225,000 | Common | SOLE |
| 68235C107 | — | ONCOCYTE CORPORATION | $716 | 0.52% | 330,000 | Common | SOLE |
| 431636109 | HLMN | HILLMAN SOLUTIONS CORP | $699 | 0.51% | 65,000 | Common | SOLE |
| 023135106 | AMZN | AMAZON.COM INC | $667 | 0.48% | 200 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $644 | 0.47% | 33,900 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $621 | 0.45% | 46,000 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $616 | 0.45% | 102,500 | Common | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $581 | 0.42% | 33,500 | Common | SOLE |
| 127097103 | CTRA | COTERRA ENERGY INC | $570 | 0.41% | 30,000 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $523 | 0.38% | 62,500 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $514 | 0.37% | 40,000 | Common | SOLE |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $486 | 0.35% | 60,000 | Common | SOLE |
| 25278X109 | FANG | DIAMONDBACK ENERGY INC | $485 | 0.35% | 4,500 | Common | SOLE |
| 09075P105 | BTAIEUR | BIOXCEL THERAPEUTICS INC | $407 | 0.29% | 20,000 | Common | SOLE |
| H5919C104 | ONON | ON HLDNG AG | $397 | 0.29% | 10,500 | Common | SOLE |
| 54570M108 | — | LOTTERY COM INC | $389 | 0.28% | 61,000 | Common | SOLE |
| 231269200 | — | CURIS INC | $381 | 0.28% | 80,000 | Common | SOLE |
| 25402D102 | DOCN | DIGITALOCEAN HLDGS INC | $361 | 0.26% | 4,500 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $338 | 0.24% | 90,000 | Common | SOLE |
| 57055L107 | — | MARKER THERAPEUTICS INC | $337 | 0.24% | 354,400 | Common | SOLE |
| 26142Q205 | — | DRAGANFLY INC | $318 | 0.23% | 195,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $286 | 0.21% | 13,500 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $274 | 0.20% | 27,500 | Common | SOLE |
| 13321L108 | CCJ | CAMECO CORP | $262 | 0.19% | 12,000 | Common | SOLE |
| 05070N103 | — | AUDACY INC | $251 | 0.18% | 97,500 | Common | SOLE |
| 58490H107 | MDNAF | MEDICENNA THERAPEUTICS CORP | $249 | 0.18% | 152,500 | Common | SOLE |
| 69242L106 | OYST | OYSTER PT PHARMA INC | $247 | 0.18% | 13,500 | Common | SOLE |
| 829399104 | — | SIO GENE THERAPIES INC | $239 | 0.17% | 185,000 | Common | SOLE |
| 00507W206 | ATNM | ACTINIUM PHARMACEUTICALS INC | $225 | 0.16% | 37,500 | Common | SOLE |
| 00973W102 | — | AKERNA CORP | $224 | 0.16% | 128,000 | Common | SOLE |
| 60800C109 | — | MOGO INC | $188 | 0.14% | 55,000 | Common | SOLE |
| 42328V603 | — | HELIUS MED TECHNOLOGIES INC | $183 | 0.13% | 35,263 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $179 | 0.13% | 20,000 | Common | SOLE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $171 | 0.12% | 15,000 | Common | SOLE |
| 45783C101 | — | INSTIL BIO INC | $171 | 0.12% | 10,000 | Common | SOLE |
| 03209T109 | — | AMPIO PHARMACEUTICALS INC | $166 | 0.12% | 291,500 | Common | SOLE |
| M4130Y106 | ENLV | ENLIVEX THERAPEUTICS LTD | $156 | 0.11% | 25,000 | Common | SOLE |
| 54570M116 | LTRYW | LOTTERY COM INC | $149 | 0.11% | 125,000 | Common | SOLE |
| 23283X206 | CTSO | CYTOSORBENTS CORP | $147 | 0.11% | 35,000 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $145 | 0.10% | 9,200 | Common | SOLE |
| 15117F500 | — | CELLECTAR BIOSCIENCES INC | $144 | 0.10% | 217,500 | Common | SOLE |
| 78472W104 | SQZB | SQZ BIOTECHNOLOGIES CO | $143 | 0.10% | 16,000 | Common | SOLE |
| 12482W101 | — | CBDMD INC | $135 | 0.10% | 125,000 | Common | SOLE |
| 89357L105 | — | TRANSCODE THERAPEUTICS INC | $127 | 0.09% | 50,000 | Common | SOLE |
| 98459U103 | YALA | YALLA GROUP LTD | $91 | 0.07% | 13,500 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $85 | 0.06% | 10,500 | Common | SOLE |
| 868153107 | SDPIUSD | SUPERIOR DRILLING PRODS INC | $79 | 0.06% | 107,500 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $79 | 0.06% | 28,500 | Common | SOLE |
| 87184Q107 | — | SYROS PHARMACEUTICALS INC | $70 | 0.05% | 21,500 | Common | SOLE |
| 09071M205 | — | BIOLINE RX LTD | $56 | 0.04% | 27,500 | Common | SOLE |
| 37186H100 | — | GENETRON HOLDINGS LIMITED | $46 | 0.03% | 7,500 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $22 | 0.02% | 10,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $19 | 0.01% | 1,000 | Common | SOLE |
| 053734604 | — | AVINGER INC | $16 | 0.01% | 35,000 | Common | SOLE |
| 03835L207 | APVOEUR | APTEVO THERAPEUTICS INC | $12 | 0.01% | 1,500 | Common | SOLE |
| 009066101 | ABNB | AIRBNB INC | $8 | 0.01% | 50 | Common | SOLE |
| 372427401 | GNCAQ | GENOCEA BIOSCIENCES INC | $6 | 0.00% | 5,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.